These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27251775)

  • 41. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
    Dezvarei S; Lee JHZ; Bell SG
    Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering.
    Sun Y; Huang X; Osawa Y; Chen YE; Zhang H
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
    Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
    Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterisation of CYP102A25 from Bacillus marmarensis and CYP102A26 from Pontibacillus halophilus: P450 Homologues of BM3 with Preference towards Hydroxylation of Medium-Chain Fatty Acids.
    Porter JL; Manning J; Sabatini S; Tavanti M; Turner NJ; Flitsch SL
    Chembiochem; 2018 Mar; 19(5):513-520. PubMed ID: 29219229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis.
    Lentz O; Urlacher V; Schmid RD
    J Biotechnol; 2004 Feb; 108(1):41-9. PubMed ID: 14741768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
    Huang WC; Cullis PM; Raven EL; Roberts GC
    Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes.
    Appel D; Lutz-Wahl S; Fischer P; Schwaneberg U; Schmid RD
    J Biotechnol; 2001 Jun; 88(2):167-71. PubMed ID: 11403851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regio- and stereo-selective 1β-hydroxylation of lithocholic acid by cytochrome P450 BM3 mutants.
    Li H; Dai W; Qin S; Li S; Yu Y; Zhang L
    Biotechnol Bioeng; 2023 Aug; 120(8):2230-2241. PubMed ID: 37424513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CYP106A2-A versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds.
    Schmitz D; Janocha S; Kiss FM; Bernhardt R
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):11-22. PubMed ID: 28780179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
    Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
    Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein engineering of CYP105s for their industrial uses.
    Yasuda K; Sugimoto H; Hayashi K; Takita T; Yasukawa K; Ohta M; Kamakura M; Ikushiro S; Shiro Y; Sakaki T
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):23-31. PubMed ID: 28583351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective ϖ-1 oxidation of fatty acids by CYP147G1 from Mycobacterium marinum.
    Child SA; Rossi VP; Bell SG
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):408-417. PubMed ID: 30476524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Directed Evolution of P450 BM3 towards Functionalization of Aromatic O-Heterocycles.
    Santos GA; Dhoke GV; Davari MD; Ruff AJ; Schwaneberg U
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chain length-dependent cooperativity in fatty acid binding and oxidation by cytochrome P450BM3 (CYP102A1).
    Rowlatt B; Yorke JA; Strong AJ; Whitehouse CJ; Bell SG; Wong LL
    Protein Cell; 2011 Aug; 2(8):656-71. PubMed ID: 21904981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP52A23 from Candida albicans and its Substrate Preference for Fatty Acid Hydroxylation.
    Park HG; Kim V; Kim H; Lee R; Cho MA; Park SW; Chun YJ; Kim D
    Arch Biochem Biophys; 2019 Aug; 671():27-34. PubMed ID: 31181182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cloning, expression and characterisation of CYP102A7, a self-sufficient P450 monooxygenase from Bacillus licheniformis.
    Dietrich M; Eiben S; Asta C; Do TA; Pleiss J; Urlacher VB
    Appl Microbiol Biotechnol; 2008 Jul; 79(6):931-40. PubMed ID: 18483737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.